An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label Phase 1 study in healthy premenopausal females evaluating the effects
of different dosing regimens of elagolix on ovarian activity, ovulation, and ovarian reserve
and to assess the effect of elagolix on selected endocrine/hormone levels.